Overall market sentiment has been neutral on BioVie Inc (BIVI) stock lately. BIVI receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.
BioVie Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on BIVI!
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With BIVI Stock Today?
BioVie Inc (BIVI) stock is down -61.71% while the S&P 500 is up 0.27% as of 10:34 AM on Wednesday, Nov 29. BIVI is down -$3.08 from the previous closing price of $4.99 on volume of 4,465,281 shares. Over the past year the S&P 500 is higher by 15.21% while BIVI is down -69.34%. BIVI lost -$1.47 per share in the over the last 12 months.
More About BioVie Inc
BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Click Here to get the full Stock Report for BioVie Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
